搜尋
Clearmind Medicine Inc
CMND添加自選
2.360USD
+0.060+2.61%
收盤 07/02, 13:00（美東）報價延遲15分鐘
240.51K總市值
虧損本益比TTM
關於 Clearmind Medicine Inc 公司
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Clearmind Medicine Inc簡介
公司代碼CMND
公司名稱Clearmind Medicine Inc
上市日期Aug 10, 2021
CEOZuloff-Shani (Adi)
員工數量- -
證券類型Ordinary Share
年結日Aug 10
公司地址101-1220 West 6Th Avenue
城市VANCOUVER
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Canada
郵編V6H 1A5
電話16042601566
網址https://www.clearmindmedicine.com/
公司代碼CMND
上市日期Aug 10, 2021
CEOZuloff-Shani (Adi)
Clearmind Medicine Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
462.00
+78.35%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
187.00
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
94.00
--
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
71.00
+11.27%
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%
Mr. Yehonatan Shachar
Mr. Yehonatan Shachar
Independent Director
Independent Director
--
--
Ms. Hila Kiron-Revach
Ms. Hila Kiron-Revach
Director
Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
462.00
+78.35%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
187.00
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
94.00
--
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
71.00
+11.27%
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%
常見問題
Clearmind Medicine Inc的前五大股東是誰？
Clearmind Medicine Inc的前五大股東如下：Mr. Amitay Weiss
有多少機構持有Clearmind Medicine Inc(CMND)的股份？
截至2026Q1，共有18家機構持有Clearmind Medicine Inc的股份，合計持有的股份價值約為7.38K，占公司總股份的0.49% 。與2025Q4相比，機構持股有所增加，增幅為-15258.00。